Catalent Expert to Present Insights on Quality & Regulatory Best Practices for Global Pharma Supply at the 3rd Annual FDA Supplier Quality Management Congress
Somerset, NJ, August 8, 2011 – Elaine Dymond, Vice-President, Global Quality at Catalent Pharma Solutions, along with other industry experts, will present at the 3rd Annual FDA Supplier Quality Management Congress, August 9-11, 2011, in Bethesda, MD. Ms. Dymond’s presentation, “Qualification, Monitoring and Challenges in Working with International Suppliers” will take place on August 9, 2011.
Attendees of the talk will gain insights on the unique challenges faced by the pharmaceutical industry when dealing with global suppliers, specifically from within Europe and the U.S. Ms. Dymond will highlight the diverse rules and regulations associated with supply, specifically meeting QP (Qualified Person) requirements, and how to overcome and mitigate the wide-range of risks and varying complexity of obtaining materials and components from international suppliers. Delegates will leaving with a better understanding of common issues faced when working with international suppliers and best practices for overcoming these challenges.
For more information on this conference and to register, please visit: www.fdanews.com
Ms. Dymond, currently based in the UK, provides Catalent with quality and regulatory leadership across the softgel and modified release technology businesses in Europe, Switzerland, Japan, and Australia. Ms. Dymond has over 25 years of pharmaceutical industry experience, where she has developed an extensive understanding of GMP and managerial responsibilites. She has held a variety of global technical and management roles overseeing quality, compliance, validation, and quality control for sterile, biological, solid, softgel and modified release dosage forms.
After studying Microbiology at Bristol West University, Ms. Dymond initially worked as a Bacteriologist/Parasitologist in the UK National Health Service. She then transferred into the pharma industry starting at The Wellcome Foundation, followed by GlaxoSmithKline, Sanofi-Aventis, Schering-Plough/Merck as the Head of Biological Quality in the UK, before joining Catalent in 2010. Ms. Dymond holds an MSc degree in Biomedics from Surrey/Open University and has studied Business Management during her employment.
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 8,000 people at 24 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ.